Yüklüyor......

Prenatal NAP+SAL Prevents Developmental Delay in Down Syndrome through affects on NMDA and GABA receptors

OBJECTIVE: Down Syndrome affects 1/800 infants. Prenatal NAP+SAL prevents developmental delay in Ts65Dn mice. We investigated if this finding involves NMDA and GABA receptor subunits. STUDY DESIGN: Pregnant Ts65Dn mice were treated with placebo or NAP+SAL on gestational days 8-12. After developmenta...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Am J Obstet Gynecol
Asıl Yazarlar: VINK, Joy, INCERTI, Maddelena, TOSO, Laura, ROBERSON, Robin, ABEBE, Daniel, SPONG, Catherine Y.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2009
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6503529/
https://ncbi.nlm.nih.gov/pubmed/19327737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2009.01.052
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!